Compare MIST & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | SBI |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.3M | 108.9M |
| IPO Year | 2019 | N/A |
| Metric | MIST | SBI |
|---|---|---|
| Price | $0.36 | $7.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.14 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 59.9K |
| Earning Date | 11-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $210.30 | N/A |
| Revenue Next Year | $251.88 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $6.86 |
| 52 Week High | $3.06 | $8.01 |
| Indicator | MIST | SBI |
|---|---|---|
| Relative Strength Index (RSI) | 24.59 | 43.67 |
| Support Level | N/A | $7.07 |
| Resistance Level | $0.84 | $7.37 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 0.00 | 0.91 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager.